Christopher R Cornell

Title: The Innovative Contributions of Christopher R Cornell

Introduction

Christopher R Cornell is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of polymorphic forms of compounds aimed at treating various oxidative stress disorders. With a total of 4 patents to his name, his work continues to impact the scientific community.

Latest Patents

Cornell's latest patents focus on the polymorphic and amorphous forms of (R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide. These patents disclose various forms, including anhydrate, hydrate, and solvates of the compound. The methods outlined in these patents are designed for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases, and diseases of aging. Furthermore, the patents detail methods for producing these polymorphic and amorphous forms.

Career Highlights

Throughout his career, Christopher R Cornell has worked with several prominent companies, including Bioelectron Technology Corporation and Edison Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Kieron E Wesson and Paul Mollard. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical solutions.

Conclusion

Christopher R Cornell's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in treating oxidative stress disorders.